Projects per year
Personal profile
Personal profile
Dr. William G. Ondo is the director of the Movement Disorders Clinic at the Houston Methodist Neurological Institute. Dr. Ondo has been in practice for nearly 20 years and specializes in diagnosis, treatment and research of Parkinson’s disease, essential tremors, the use of botulinum toxins in treating movement disorders, and restless legs syndrome.
Dr. Ondo earned his medical degree from the Medical College of Virginia before completing an internship at the University of North Carolina Hospital, a neurology residency at Duke University, and a movement disorders fellowship at the Baylor College of Medicine. He is board certified by the American Board of Psychiatry and Neurology in adult neurology and sleep medicine. He has authored more than 250 original articles and book chapters as well as edited two books on movement disorders. He currently serves as the president of the Tremor Research Group.
Research Area Keywords
- Neurosciences
- Clinical Translation & Trials
Free-text keywords
- Ataxia
- Parkinson's disease
- Dystonia
- Essential tremor
- Restless legs
Fingerprint
Dive into the research topics where William G. Ondo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Randomized Placebo-controlled Trial of Zoledronic Acid for Prevention of Fractures in Patients with Parkinson¿s Disease
7/14/21 → 7/13/23
Project: Non Profit
-
-
Consensus guidelines on the construct validity of rodent models of restless legs syndrome
the International Restless Legs Syndrome Study Group (IRLSSG), Aug 2022, In: DMM Disease Models and Mechanisms. 15, 8, dmm049615.Research output: Contribution to journal › Article › peer-review
Open Access -
Enhancing GABA inhibition is the next generation of medications for essential tremor
Ondo, W., Jan 2022, Essential Tremor: Current Concepts and Controversies. Kuo, S-H. & Louis, E. D. (eds.). Academic Press, p. 317-334 18 p. (International Review of Neurobiology; vol. 163).Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Exploratory cross-over, trial of augmented RLS with the dopamine receptor 1/5 antagonist ecopipam D1/D5 antagonist ecopipam for augmented RLS
Ondo, W. G. & Olubajo, T., 2022, In: International Journal of Neuroscience. 132, 8, p. 778-782 5 p.Research output: Contribution to journal › Article › peer-review
-
Stroke-related restless legs syndrome: epidemiology, clinical characteristics, and pathophysiology
Wang, X. X., Feng, Y., Tan, E. K., Ondo, W. G. & Wu, Y. C., Feb 2022, In: Sleep Medicine. 90, p. 238-248 11 p.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial
for the THN102-202 Study Investigators, Feb 2022, In: Movement Disorders. 37, 2, p. 410-415 6 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations